Invitation Homes Inc. · INVH · FY2025 Q2 · Calendar Q3 2025
Invitation Homes: Growth initiatives advance, while occupancy risks remain
The supplied analysis supports a balanced view: resilient demand, renewal strength and acquisition initiatives support the growth case, while occupancy deceleration, new supply and cost uncertainty limit conviction.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about INVH FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, management added emphasis to developer lending and continued a robust acquisition program, while the discussion placed more focus on seasonal occupancy deceleration, new-lease pricing and market supply.
Guidance delta
Management maintained its outlook; the analysis did not identify a guidance change.
Key takeaways
- Management described resilient resident demand and renewal trends as support for cash-flow stability.
- Acquisitions, builder partnerships, capital recycling and developer lending remain central to the growth plan.
- The main counterweight is a potential seasonal occupancy slowdown alongside supply and property-tax uncertainty.
Management priorities
- Continue acquisitions and capital recycling while targeting attractive yields.
- Scale developer-lending and builder relationships to participate earlier in build-to-rent development.
- Protect resident retention and monitor occupancy and market-specific supply conditions.
Follow INVH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 10, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Neutral | Upgrade | Sep 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 21, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Sep 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 25, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Aug 5, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 14, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Jun 24, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jun 15, 2026 |
| CFRA | Sell | Hold | Downgrade | May 28, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | May 18, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Mar 9, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 25, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Feb 20, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Feb 20, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Nov 12, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | May 6, 2025 |
| Keefe, Bruyette& Woods | Market Perform | Market Perform | Maintain | May 5, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Jan 21, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Dec 12, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 2, 2024 |
| BTIG | Neutral | Buy | Downgrade | Aug 17, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jan 9, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Nov 30, 2022 |
| Berenberg | Hold | Buy | Downgrade | Aug 16, 2021 |
| Zelman | Hold | Buy | Downgrade | Jun 24, 2021 |
| Janney Capital | Buy | Buy | Maintain | Jun 18, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | Jun 16, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | Jun 16, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 19, 2019 |
| Baird | Outperform | Outperform | Maintain | Mar 29, 2018 |
| BTIG Research | Buy | Buy | Maintain | Oct 9, 2017 |
Named analyst price targets
Upside is calculated against the persisted current price $26.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $32 | $26.91 | +19.4% | Sep 21, 2026 |
| BTIG | Analyst unavailable | $32 | $26.91 | +19.4% | Sep 21, 2026 |
| Scotiabank | Analyst unavailable | $28 | $27.3 | +4.5% | Sep 17, 2026 |
| Oppenheimer | Tyler Batory | $33 | $30.4 | +23.2% | Aug 3, 2026 |
| Wells Fargo | Analyst unavailable | $33 | $29.05 | +23.2% | Jun 24, 2026 |
| Scotiabank | Nicholas Yulico | $30 | $28.64 | +12.0% | Jun 18, 2026 |
| Mizuho Securities | Analyst unavailable | $31 | $29 | +15.7% | Jun 17, 2026 |
| BMO Capital | Juan Sanabria | $35 | $29.68 | +30.6% | Jun 15, 2026 |
| CFRA | Analyst unavailable | $27 | $29.41 | +0.8% | May 27, 2026 |
| Scotiabank | Analyst unavailable | $29 | $29.05 | +8.2% | May 21, 2026 |
| UBS | Analyst unavailable | $32 | $28.62 | +19.4% | May 19, 2026 |
| Raymond James | Buck Horne | $32 | $27.93 | +19.4% | May 18, 2026 |
| Evercore ISI | Analyst unavailable | $32 | $28.76 | +19.4% | May 1, 2026 |
| Compass Point | Analyst unavailable | $30 | $27.23 | +12.0% | Apr 28, 2026 |
| Barclays | Analyst unavailable | $32 | $27.13 | +19.4% | Apr 27, 2026 |
| Morgan Stanley | Adam Kramer | $33 | $25.97 | +23.2% | Mar 9, 2026 |
| Oppenheimer | Tyler Batory | $31 | $25.38 | +15.7% | Feb 24, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $26 | +15.7% | Feb 20, 2026 |
| KeyBanc | Analyst unavailable | $34 | $25.68 | +26.9% | Feb 20, 2026 |
| UBS | Analyst unavailable | $40 | $27.29 | +49.3% | Jan 21, 2026 |
| UBS | Analyst unavailable | $28 | $26.52 | +4.5% | Jan 14, 2026 |
| Barclays | Richard Hightower | $33 | $26.14 | +23.2% | Jan 13, 2026 |
| UBS | Michael Goldsmith | $35 | $26.41 | +30.6% | Jan 8, 2026 |
| Mizuho Securities | Analyst unavailable | $27 | $26.41 | +0.8% | Jan 8, 2026 |
| Barclays | Analyst unavailable | $34 | $28.14 | +26.9% | Nov 25, 2025 |
| Scotiabank | Nicholas Yulico | $31 | $27.89 | +15.7% | Nov 10, 2025 |
| Oppenheimer | Tyler Batory | $38 | $28.36 | +41.8% | Nov 4, 2025 |
| Evercore ISI | Analyst unavailable | $33 | $28.14 | +23.2% | Oct 31, 2025 |
| Mizuho Securities | Analyst unavailable | $30 | $28.6 | +12.0% | Oct 21, 2025 |
| Wells Fargo | Analyst unavailable | $31 | $27.9 | +15.7% | Oct 13, 2025 |
| Evercore ISI | Analyst unavailable | $35 | $30.21 | +30.6% | Sep 15, 2025 |
| RBC Capital | Analyst unavailable | $35 | $34.01 | +30.6% | Feb 28, 2025 |
| Barclays | Richard Hightower | $36 | $30.52 | +34.4% | Jan 24, 2025 |
| CFRA | Kenneth Leon | $38 | $35.66 | +41.8% | Sep 25, 2024 |
| Bank of America Securities | Jeffrey Spector | $37 | $36.5 | +38.1% | Sep 24, 2024 |
| Goldman Sachs | Julien Blouin | $46 | $37.27 | +71.7% | Sep 4, 2024 |
| Wells Fargo | James Feldman | $38 | $36.15 | +41.8% | Aug 26, 2024 |
| RBC Capital | Brad Heffern | $37 | $34.12 | +38.1% | Jul 26, 2024 |
| Evercore ISI | Steve Sakwa | $37 | $34.12 | +38.1% | Jul 26, 2024 |
| Deutsche Bank | Derek Johnston | $41 | $33.21 | +53.0% | Jul 24, 2024 |
| Evercore ISI | Steve Sakwa | $36 | $34.62 | +34.4% | Mar 18, 2024 |
| Oppenheimer | Tyler Batory | $35 | $29.32 | +30.6% | Oct 30, 2023 |
| Jefferies | Linda Tsai | $31 | $29.64 | +15.7% | Jan 2, 2023 |
| Barclays | Anthony Powell | $39 | $31.15 | +45.6% | Dec 13, 2022 |
| Goldman Sachs | Analyst unavailable | $35 | $32.18 | +30.6% | Dec 8, 2022 |
| Goldman Sachs | Analyst unavailable | $45 | $39.72 | +68.0% | Aug 16, 2022 |
| Mizuho Securities | Analyst unavailable | $44 | $36.09 | +64.2% | Jul 6, 2022 |
| Jefferies | Analyst unavailable | $41 | $35.58 | +53.0% | Jun 30, 2022 |
| Raymond James | Analyst unavailable | $44 | $34.05 | +64.2% | Jun 23, 2022 |
| Credit Suisse | Analyst unavailable | $47 | $43.08 | +75.4% | Apr 25, 2022 |
| Jefferies | Analyst unavailable | $48 | $43.83 | +79.2% | Apr 20, 2022 |
| BTIG | James Sullivan | $50 | $40.68 | +86.6% | Nov 15, 2021 |
| Raymond James | Buck Horne | $48 | $41.11 | +79.2% | Nov 3, 2021 |
| Goldman Sachs | Chandni Luthra | $47 | $40.08 | +75.4% | Sep 23, 2021 |
| Barclays | Anthony Powell | $46 | $41.54 | +71.7% | Sep 1, 2021 |
| B.Riley Financial | Craig Kucera | $46 | $39.25 | +71.7% | Aug 17, 2021 |
| Credit Suisse | Sam Choe | $41 | $37.44 | +53.0% | Jun 10, 2021 |
Track every rating change on INVH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationInvitation Homes Inc., an S&P 500 company, is the nation’s premier single-family home leasing and management company, helping to expand housing through new development and strategic partnerships. Their purpose, Unlock the Power of Home, reflects their commitment to address America’s housing needs by delivering high-quality living solutions and genuine care to those who choose the flexibility and value of leasing. Invitation Homes Inc. was incorporated in 6th June 2012 and is based in Dallas, United States.
Historical context
All INVH earningsLatest beats and misses
Who reports nextBeat on EPS
Get the INVH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-10T03:20:45.046990+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-10T03:20:45.043627+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-10. For educational purposes only; not investment advice.